Tech Company Financing Transactions

diaDexus Funding Round

On 3/31/2006, diaDexus received $7.5 million in funding from Burrill & Company and Mosaix Ventures.

Transaction Overview

Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
343 Oyster Point Boulevard
South San Francisco, CA 94080
USA
Email Address
Overview
diaDexus was formed in 1997 as a joint venture by SmithKline Beecham and Incyte. SmithKline Beecham granted diaDexus an exclusive license to certain diagnostic intellectual property, and Incyte contributed free access to its databases.
Profile
diaDexus LinkedIn Company Profile
Social Media
diaDexus Company Twitter Account
Company News
diaDexus News
Facebook
diaDexus on Facebook
YouTube
diaDexus on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Patrick Plewman
  Patrick Plewman LinkedIn Profile  Patrick Plewman Twitter Account  Patrick Plewman News  Patrick Plewman on Facebook
Chief Financial Officer
David Foster
  David Foster LinkedIn Profile  David Foster Twitter Account  David Foster News  David Foster on Facebook
Executive Vice President
Robert Wolfert
  Robert Wolfert LinkedIn Profile  Robert Wolfert Twitter Account  Robert Wolfert News  Robert Wolfert on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2006: Action Engine venture capital transaction
Next: 3/31/2006: UpdateLogic venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary